Cohen & Company Inc. (NYSEAMERICAN:COHN – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $8.71. Cohen & Company Inc. shares last traded at $8.56, with a volume of 1,385 shares.
Cohen & Company Inc. Trading Up 1.7 %
The company has a debt-to-equity ratio of 0.31, a current ratio of 0.98 and a quick ratio of 0.98. The company has a market capitalization of $16.69 million, a P/E ratio of -23.13 and a beta of 1.22.
Cohen & Company Inc. (NYSEAMERICAN:COHN – Get Free Report) last issued its quarterly earnings results on Monday, August 5th. The financial services provider reported ($1.51) earnings per share (EPS) for the quarter. Cohen & Company Inc. had a negative return on equity of 1.98% and a net margin of 4.69%. The firm had revenue of $10.80 million during the quarter.
Cohen & Company Inc. Announces Dividend
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Cohen & Company Inc. stock. Renaissance Technologies LLC purchased a new position in shares of Cohen & Company Inc. (NYSEAMERICAN:COHN – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 15,300 shares of the financial services provider’s stock, valued at approximately $136,000. Renaissance Technologies LLC owned about 0.79% of Cohen & Company Inc. as of its most recent SEC filing. Institutional investors and hedge funds own 14.26% of the company’s stock.
Cohen & Company Inc. Company Profile
Cohen & Company Inc is a publicly owned investment manager. The firm primarily provides its services to individuals and institutions. It manages separate client-focused fixed income portfolios. Institutional Financial Markets, Inc also manages funds and collateralized debt obligations for its clients.
Featured Stories
- Five stocks we like better than Cohen & Company Inc.
- Compound Interest and Why It Matters When Investing
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Does a Stock Split Mean?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Stock Dividend Cuts Happen Are You Ready?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Cohen & Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cohen & Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.